DCW Ltd Reports Q1 FY27 Results

Revenue Rs 542 crore, EBITDA Rs 41.4 crore.

Reader Takeaway: Specialty chemicals strength offsets PVC weakness; monitor capex execution and revised EBITDA target.

What just happened

DCW Ltd announced its financial results for the first quarter of FY27. Revenue increased by 14% year-on-year to Rs 542 crore. However, Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) saw a significant drop of 28% to Rs 41.4 crore.

The Specialty Chemicals segment revenue stood at Rs 177 crore, contributing 33% to the total revenue. This segment showed resilience with a 38% YoY revenue growth and a 20% YoY EBITDA growth.

Conversely, the Basic Chemicals segment reported a negative EBITDA of Rs 14 crore. This was primarily due to challenges in the PVC business, affected by VCM supply constraints from the West Asia conflict and high VCM prices. Temporary suspension of import duties also squeezed margins.

Sequentially, revenue declined 11% quarter-on-quarter due to inventory liquidation in Q4 FY26 and temporary PVC production shutdowns.

Why this matters

The results highlight a mixed performance for DCW. While the Specialty Chemicals segment is performing well and the company is on track for deleveraging, the losses in the PVC segment due to external factors present a concern. The company's planned capital expenditure and revised EBITDA targets will be crucial for future performance.

The backstory

DCW Ltd has been focusing on expanding its Specialty Chemicals business and reducing debt. The company recently appointed Sudarshan Ganapathy as its new CEO, signaling a potential shift in strategy or focus.

What changes now

DCW has announced an INR 250 crore investment program over the next 2-3 years. This includes expanding SIOP capacity and investing in captive power infrastructure at its Sahupuram facility. The company aims to be effectively net-debt-free by the end of FY27. Management indicated that VCM supply issues have normalized and import duties are reinstated, which should improve the operating environment for the PVC segment.

Risks to watch

Margin volatility in CPVC and PVC spreads due to external price fluctuations remains a key risk. The execution of the INR 250 crore capex over the next 2-3 years, with major commissioning in Q4 FY28, carries execution risk and potential for delays.

Peer comparison

While specific peer comparisons are not provided in the filing, the performance of DCW's Specialty Chemicals segment can be benchmarked against other chemical manufacturers focusing on similar product lines. The challenges faced by the PVC segment are also common to other players in the basic chemicals industry dealing with supply chain disruptions and import duty fluctuations.

Context metrics (time-bound)

• Q1 FY27 Revenue: Rs 542 crore (up 14% YoY).
• Q1 FY27 EBITDA: Rs 41.4 crore (down 28% YoY).
• Specialty Chemicals Revenue: Rs 177 crore (33% of total).
• Specialty Chemicals EBITDA Growth: 20% YoY.
• Finance Cost: Rs 14.8 crore (down 2% YoY).
• Capex Plan: INR 250 crore over 2-3 years.
• Revised Steady-State EBITDA Target: Rs 300 crore.

What to track next

Investors should closely monitor the recovery of the PVC segment, the execution of the planned capital expenditure, and the company's progress towards its revised steady-state EBITDA target of Rs 300 crore.